Media Thread, page-981

Herceptin. Note how LC kept mentioning again and again and again how Her-Vaxx is better than Herceptin? And LC would know because she was heavily involved in creating Herceptin until Roche took it over. AND, Herceptin has been a successful blockbuster for Roche. So, if you put it all back together, in terms of trust, Roche can trust LC. In terms of past performance, Herceptin has performed beautifully (financial wise) for Roche, so naturally they would believe LC again if she tells them Her-Vaxx will perform even more beautifully than Herceptin in terms of both financial and reputation as Her-Vaxx will be better in terms of efficacy, safety and tolerability. What's more, Herceptin market share has been eroded recently due to biosims. A big company like Roche won't like that.

I must stress, the above is just my speculation.